The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Spring 2022 RFA: Parkinson’s Pathway Molecular Data Analysis Program, 2026Biomarker Signatures of Parkinson’s Disease Using a Novel Progression Model
Study Rationale:
Parkinson’s disease (PD) affects everyone differently. While no two people are alike in how they experience PD, there are groups of people with PD who share similar...
-
The Bridge Initiative - Supplement: Parkin peptide binders characterization - powder reconfirm and structures, 2026The Bridge Initiative
Study Rationale:
Despite broad efforts to develop pharmacological compounds against important PD targets, such as Parkin and GBA, there is a lack of publicly available chemical...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.